HOW TO DETERMINE WHO SHOULD GET WHAT

被引：3

|

作者：

GOODIN, RE ^{[1
]}

机构：

[1] UNIV STRATHCLYDE,GLASGOW,SCOTLAND

来源：

ETHICS | 1975年 / 85卷 / 04期

关键词：

D O I：

10.1086/291970

中图分类号：

B82 [伦理学（道德学）];

学科分类号：

摘要：

引用

收藏

页码：310 / 321

页数：12

相关论文

共 50 条

[31] Adherence to CPAP What Should We Be Aiming For, and How Can We Get There?
Bakker, Jessie P.
Weaver, Terri E.
Parthasarathy, Sairam
Aloia, Mark S.
[J]. CHEST, 2019, 155 (06) : 1272 - 1287
[32] What Everyone Should Say about Symmetries (and How Humeans Get to Say It)
Hicks, Michael Townsen
[J]. PHILOSOPHY OF SCIENCE, 2019, 86 (05) : 1284 - 1294
[33] Aspirin, statins and antihypertensives: Who gets them? Who should get them? And when should they get them?
MacDonald, TM
[J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2004, 31 (11) : A215 - A215
[34] How should we determine who should regulate lawyers? Managing conflict and context in professional regulation
Wilkins, DB
[J]. FORDHAM LAW REVIEW, 1996, 65 (01) : 465 - 492
[35] The role of endosonography in esophageal carcinoma: Who should get it, who should do it?
Fockens, P
VanLanschot, JJB
Tytgat, GNJ
[J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1996, 31 : 82 - 85
[36] Raising the Question on 'Who Should Get What?' Again: On the Importance of Ideal and Existential Standards
Shamon, Hawal
Duelmer, Hermann
[J]. SOCIAL JUSTICE RESEARCH, 2014, 27 (03) : 340 - 368
[37] Raising the Question on ‘Who Should Get What?’ Again: On the Importance of Ideal and Existential Standards
Hawal Shamon
Hermann Dülmer
[J]. Social Justice Research, 2014, 27 : 340 - 368
[38] Who should get what, and why? On deservingness criteria and the conditionality of solidarity among the public
von Oorschot, W
[J]. POLICY AND POLITICS, 2000, 28 (01): : 33 - 48
[39] Family Members of Patients With ARVC Who Is at Risk? At What Age? When and How Often Should We Evaluate to Determine Risk?
Marcus, Frank
Mestroni, Luisa
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (03) : 302 - 303
[40] Who should get long-term anticoagulant therapy for venous thromboembolism and with what?
Rodger, Marc Alan
Le Gal, Gregoire
[J]. BLOOD ADVANCES, 2018, 2 (21) : 3081 - 3087

← 1 2 3 4 5 →